OTAVA was established in 1997 as a subdivision of the Institute of Molecular Biology and Genetics of the National Academy of Science of Ukraine, and focused on the synthesis and supply of high-quality novel organic compounds on an exclusive or non-exclusive basis. OTAVA specializes in drug discovery technologies, custom synthesis and development of fluorescent dyes for biomedical research. OTAVA has its North American office in Toronto, Canada.